3Provan D,Stasi R,New land AC,et al. International consensus report on the investigation and management of primary immune thromboeyto penia[J]. Blood ,2010,115 : 168-186.
4Rodeghiero F,Stasi R,Gernsheimer T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an international workinggroup.Blood,2009,113:2386-2393.
5Castella M,Pujol M,Julia A,et al.Thrombotic thrombocytopenic purpum and pregnancy:a review of ten cases.Vox Sang,2004,87:287.
6Stavrou E,McCrae KR.Immune thrombocytopenia in pregnancy.Hematol Oneol Clin North Am,2009,23:1299-1316.
7British Committee for Standards in Haematology General Haematology Task Force.Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults,children and in pregnancy.Rr J Haematol,2003,120:574-596.
8McMillan R,Wang L,Tomer A,et al.Suppression of in vitronmgakaryoeyte production by antiplatelet autoantibodies from adult patients with chronic ITP.Blood,2004,103:1364-1369.
9McMillan R.The pathogenesis of chronic immune thrombocytopeniepurpura.Semin Hematol,2007,44(4 Suppl 5);S3-11.
10George JN,Woolf SH,Raskob GE,et al.Idiopathic thrombocytopenicpurpura:a praetice guideline devdoped by explicit methods for the American Society of Hematology.Blood,1996,88:3-40.
